These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34849169)
1. Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies. Wang Y; Luo C; Zhou S; Wang X; Zhang X; Li S; Zhang S; Wang S; Sun B; He Z; Sun J Asian J Pharm Sci; 2021 Sep; 16(5):643-652. PubMed ID: 34849169 [TBL] [Abstract][Full Text] [Related]
2. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities. Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579 [TBL] [Abstract][Full Text] [Related]
3. Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy. Zhang S; Guan J; Sun M; Zhang D; Zhang H; Sun B; Guo W; Lin B; Wang Y; He Z; Luo C; Sun J Drug Deliv; 2017 Nov; 24(1):1460-1469. PubMed ID: 28950729 [TBL] [Abstract][Full Text] [Related]
4. Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies. Wang D; Du C; Wang S; Li L; Liu T; Song J; He Z; Zhai Y; Sun B; Sun J ACS Appl Mater Interfaces; 2022 Nov; 14(45):51200-51211. PubMed ID: 36397309 [TBL] [Abstract][Full Text] [Related]
5. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety. Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247 [TBL] [Abstract][Full Text] [Related]
6. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685 [TBL] [Abstract][Full Text] [Related]
7. Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment. Wang D; Huang Y; Yuan J; Wang S; Sheng J; Zhao Y; Zhang H; Wang X; Yu Y; Shi X; He Z; Liu T; Sun B; Sun J J Control Release; 2024 Nov; 375():47-59. PubMed ID: 39222794 [TBL] [Abstract][Full Text] [Related]
8. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies. Li L; Zuo S; Dong F; Liu T; Gao Y; Yang Y; Wang X; Sun J; Sun B; He Z Asian J Pharm Sci; 2021 May; 16(3):337-349. PubMed ID: 34276822 [TBL] [Abstract][Full Text] [Related]
9. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity. Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644 [TBL] [Abstract][Full Text] [Related]
10. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer. Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051 [TBL] [Abstract][Full Text] [Related]
11. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy. Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811 [TBL] [Abstract][Full Text] [Related]
12. The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies. Wang S; Liu T; Huang Y; Du C; Wang D; Wang X; Lv Q; He Z; Zhai Y; Sun B; Sun J Acta Pharm Sin B; 2024 Mar; 14(3):1400-1411. PubMed ID: 38486988 [TBL] [Abstract][Full Text] [Related]
13. Minor Changes in Response Modules Leading to a "U-Shaped" Conversion Rate of Docetaxel Prodrug Nanoassemblies. Li W; Wang D; Zhao H; Xu H; Li L; Huang Y; Shi X; Sun J; He Z; Sun B Nano Lett; 2024 Jan; 24(1):394-401. PubMed ID: 38147432 [TBL] [Abstract][Full Text] [Related]
14. Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy. Li Y; Li L; Jin Q; Liu T; Sun J; Wang Y; Yang Z; He Z; Sun B Asian J Pharm Sci; 2022 Mar; 17(2):241-252. PubMed ID: 35582643 [TBL] [Abstract][Full Text] [Related]
15. Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety. Xu H; Zuo S; Wang D; Zhang Y; Li W; Li L; Liu T; Yu Y; Lv Q; He Z; Sun J; Sun B J Control Release; 2023 Aug; 360():784-795. PubMed ID: 37451544 [TBL] [Abstract][Full Text] [Related]
16. Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction. Wang D; Li L; Xu H; Sun Y; Li W; Liu T; Li Y; Shi X; He Z; Zhai Y; Sun B; Sun J Nano Lett; 2023 Apr; 23(8):3549-3557. PubMed ID: 37053460 [TBL] [Abstract][Full Text] [Related]
17. Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity. Li G; Sun B; Zheng S; Xu L; Tao W; Zhao D; Yu J; Fu S; Zhang X; Zhang H; Zhai Y; Luo C; Ding H; He Z; Sun J Adv Healthc Mater; 2021 Dec; 10(23):e2101407. PubMed ID: 34601824 [TBL] [Abstract][Full Text] [Related]
18. Carbon-Spaced Tandem-Disulfide Bond Bridge Design Addresses Limitations of Homodimer Prodrug Nanoassemblies: Enhancing Both Stability and Activatability. Zhang H; Liu T; Sun Y; Wang S; Wang W; Kuang Z; Duan M; Du T; Liu M; Wu L; Sun F; Sheng J; He Z; Sun J J Am Chem Soc; 2024 Aug; 146(32):22675-22688. PubMed ID: 39088029 [TBL] [Abstract][Full Text] [Related]
19. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment. Liu T; Li L; Wang S; Dong F; Zuo S; Song J; Wang X; Lu Q; Wang H; Zhang H; Cheng M; Liu X; He Z; Sun B; Sun J Nat Commun; 2022 Nov; 13(1):7228. PubMed ID: 36434014 [TBL] [Abstract][Full Text] [Related]
20. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965 [No Abstract] [Full Text] [Related] [Next] [New Search]